Health & Medicine
-
NHS Strikes Conclude After Two Years of Fragmented Disputes Across UK
/ HTML. So we can have headings and paragraphs . No extra tags. Must not add new info. Must not invent quotes,…
-
NHS Strikes Resolved After Two-Year Dispute
United Kingdom, September 18, 2024 — cybernewschronicle.com — The 2022–2024 National Health Service (NHS) strikes were a series of concurrent industrial disputes…
-
Atezolizumab Hyaluronidase Approved For Cancer Treatment In United States
Atezolizumab/hyaluronidase, a fixed-dose combination medication, has been approved for medical use in the United States as of September 2024, marking a significant…
-
FDA approves Tecentriq Hybreza shot, replacing lengthy IV infusions
Targeted cancers and mechanism of action The approval covers non‑small cell lung cancer, small‑cell lung cancer, hepatocellular carcinoma, melanoma and the rare…
-
FDA Approves First Non-Dopamine Schizophrenia Drug
September 17, 2024 — cybernewschronicle.com — For decades, the standard treatment for schizophrenia has revolved around one brain system: dopamine. Every major…
-
FDA Approves New Schizophrenia Medication With Unique Mechanism
The U.S. Food and Drug Administration granted approval on September 15, 2024, for a new fixed-dose combination medication designed to treat schizophrenia.…
-
Pfizer Drug Ponsegromab Boosts Weight in Cachexia Trial
Cancer patients losing dangerous amounts of weight have long had few medical options. A monoclonal antibody called ponsegromab might change that. Pfizer…
-
Pfizer Announces Breakthrough in Cancer Cachexia Treatment Development Progress
On September 15, 2024, Pfizer announced findings from a phase 2 clinical trial for ponsegromab, a monoclonal antibody designed to treat cancer…
-
Gabon confirms first mpox case after man flew from Uganda.
Health authorities in Gabon announced on August 23 that a man who arrived by air from Uganda has tested positive for mpox.…
-
Gabon Reports First Mpox Case in Traveler from Uganda Recently
Health authorities in Gabon have confirmed the Central African nation’s first case of mpox, a viral disease, in a male patient who…
-
FDA Approves First Pill for Slow-Growing Brain Cancer Treatment
Each year, about 1,500 Americans receive a diagnosis of grade 2 glioma, a slowly progressing yet aggressive brain tumor. Until now, treatment…
-
Make America Healthy Again Movement Gains Momentum Nationwide Suddenly
WASHINGTON, D.C. — The slogan “Make America Healthy Again” is not new. Its roots stretch back decades through the public-health work of…
-
New Treatment Option Arrives for Non-Small Cell Lung Cancer Patients
The U.S. Food and Drug Administration authorized a new medication for non-small cell lung cancer on August 15, 2024. The drug, Lazertinib,…
-
FDA Approves Lazertinib for Lung Cancer Patients
For patients with a common form of lung cancer, a new treatment option arrived in the United States on August 15, 2024.…
-
New Lung Cancer Treatment Option Arrives in United States Market
On August 15, 2024, the United States Food and Drug Administration authorized the use of Lazertinib for patients diagnosed with non-small cell…
-
EU Approves New Lymphoma Treatment Odronextamab for Patients
European patients with two forms of lymphoma now have access to a newly approved medication that works through a distinctive biological mechanism.…
-
Gaza Records First Polio Case in 25 Years
Deir al-Balah, August 16, 2024 — cybernewschronicle.com — For 25 years, the Gaza Strip had no polio. Now it does. A 10-month-old…
-
FDA Approves New Drug for Chronic Graft-Versus-Host Disease Treatment
/ HTML. Length 450-560 words. Must not add any extra content. Must not invent quotes. Must keep facts: August 2024, FDA approved…
-
Axatilimab Approved For Chronic Graft Versus Host Disease Treatment
United States, August 16, 2024 — infopulsetoday.com — Axatilimab, a monoclonal antibody marketed under the brand name Niktimvo, has been approved for…
-
Polio Confirmed in Gaza Child After 25-Year Absence
The first case of polio in the Gaza Strip in 25 years has been confirmed, sparking concern among health officials. According to…
-
Lazertinib Approved in US for Non-Small Cell Lung Cancer
Lazertinib, a medication used to treat non-small cell lung cancer, has recently been approved for medical use in the United States as…
-
Lazertinib Approved in US for Non-Small Cell Lung Cancer Treatment
In August 2024, the U.S. Food and Drug Administration granted approval for lazertinib, expanding the therapeutic arsenal against non‑small cell lung cancer…
-
WHO Declares Mpox Epidemic a Global Public Health Emergency Concern
The World Health Organization designated the ongoing mpox epidemic a public health emergency of international concern on August 14, 2024. This classification…
-
Mpox Crisis in Central Africa Declared Global Health Emergency
Since September 2023, Central Africa has recorded more than 29,000 cases of mpox, with the death toll surpassing 800. The fatality ratio…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Sugar‑sweetened beverages raise teen anxiety and depression risk, Australian study finds
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
MD Anderson Breakthroughs Advance Immunotherapy for Lung Cancer
-
How Modern Immunotherapy Is Redefining Cancer Treatment Beyond Chemotherapy
-
26% of Americans Spend More Than They Earn as Credit Card Debt Rises and Budgets Tighten
-
How Medicaid Estate Recovery Claims Decedents’ Homes Through Premiums
-
How Insurance Agent Commissions Drive Medicare Advantage Enrollments
-
How Medicare Advantage Plans Hide the 63-Day Medigap Window—and What It Costs You to Miss It
-
How Mortgage Rates Could Shift Over the Next Five Years
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
Theo Burrell’s death sparks renewed calls for brain cancer research funding
-
Thousands embrace mud and purpose at Heaton Park Pretty Muddy run.
-
Study Links Lung Tumor Mutation, High-Fat Diet, and Nerve Pathway to Wasting Syndrome
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds